Management of large giant cell tumors of the proximal humerus is controversial because wide resection with reconstruction
results in a poor functional outcome for most patients. We retrospectively reviewed the cases of six patients with Campanacci
Grade III giant cell tumors of the proximal humerus to determine the feasibility of avoiding en bloc resections for large
giant cell tumors in this location. We evacuated the tumor through curettage and then used burring (unless the remaining cavity
was thinned and at risk for fracture) and phenolization, followed by packing of the defect with allograft cancellous bone.
The mean age of the patients at surgery was 30 years, and the minimum followup was 2.5 years (mean, 5.6 years; range, 2.5–9.7 years).
One of the six patients had local recurrence 1.2 years postoperatively and was treated with repeat intralesional surgery with
no additional recurrence 5 years later. No other patient required additional treatment, had pulmonary metastases develop,
or had progression to osteoarthritis. The mean Musculoskeletal Tumor Society and Toronto Extremity Salvage Score functional
scores at last followup were 26 of 30 (range, 21–30) and 95% (range, 90%–100%), respectively. These functional scores are
higher than reported scores for patients with segmental resection and reconstruction of the proximal humerus.
Level of Evidence: Level IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.
One or more of the authors (EAC, JJK, RDL) have received funding from Stryker Orthopaedics.
Each author certifies that his or her institution has approved or waived approval for the human protocol for this investigation
and that all investigations were conducted in conformity with ethical principles of research.